0800 085 6464 - 9:00am to 5:00pm - Mon to Fri

Healthy Volunteers Trials

Healthy black male and female participants aged 18 to 45

£1,732
(C21007) Cohort 1
Age:
18-45
London Bridge

We are conducting a clinical trial, in healthy black volunteers of Sub-Saharan African origin, for potential future use in the prevention of malaria.

Healthy black male and female participants aged 18 to 45

£1,732
Age:
18-45
London Bridge
(C21007) Cohort 1

We are conducting a clinical trial, in healthy black volunteers of Sub-Saharan African origin, for potential future use in the prevention of malaria.

Healthy volunteers aged 18 to 45

Reimbursed travel expenses
(C18022)
Age:
18-45
London Bridge

Free screening and vaccination for healthy volunteers aged 18 to 45.

Healthy volunteers aged 18 to 45

Reimbursed travel expenses
Age:
18-45
London Bridge
(C18022)

Free screening and vaccination for healthy volunteers aged 18 to 45.

Healthy male and female volunteers

£3,116
(C21014) Cohort 10
Age:
18-45
London Bridge

We are conducting a clinical trial for a new medicine that could be used to treat people with diseases involving dysregulation of part of the immune system.

Healthy male and female volunteers

£3,116
Age:
18-45
London Bridge
(C21014) Cohort 10

We are conducting a clinical trial for a new medicine that could be used to treat people with diseases involving dysregulation of part of the immune system.

Healthy Caucasian male and female participants aged 20 to 40

£2,094
(C21015) Part A Cohort 3
Age:
20-40
London Bridge

We are conducting a clinical trial for an investigational medicine that could be used to treat people with Respiratory Syncytial Virus.

Healthy Caucasian male and female participants aged 20 to 40

£2,094
Age:
20-40
London Bridge
(C21015) Part A Cohort 3

We are conducting a clinical trial for an investigational medicine that could be used to treat people with Respiratory Syncytial Virus.

Patient Trials

Private medical checkup for male and female patients aged 18 to 65

Reimbursed travel expenses
Age:
18-65
London Bridge
Private medical checkup for male and female patients aged 18 to 65

We are looking for people with, type 1 or type 2 diabetes, high blood pressure (hypertension), non-alcoholic steatohepatitis (NASH), or heart failure.

Private medical checkup for male and female patients aged 18 to 65

Reimbursed travel expenses
This is some text inside of a div block.
Private medical checkup for male and female patients aged 18 to 65
London Bridge

We are looking for people with, type 1 or type 2 diabetes, high blood pressure (hypertension), non-alcoholic steatohepatitis (NASH), or heart failure.

Type 2 Diabetic Caucasian male and female patients

£948
Age:
18-65
London Bridge
(C19040)

We are looking for Caucasian men and women with type 2 diabetes aged 18 to 65 years to test a potential medicine to treat type 2 diabetes.

Type 2 Diabetic Caucasian male and female patients

£948
This is some text inside of a div block.
(C19040)
London Bridge

We are looking for Caucasian men and women with type 2 diabetes aged 18 to 65 years to test a potential medicine to treat type 2 diabetes.

Male and female patients with Wilson disease

£6,420
Age:
18+
London Bridge
(C19048)

We are looking for up to 10 men and women with Wilson Disease aged 18 years or older to test a potential medicine for treating Wilson Disease.

Male and female patients with Wilson disease

£6,420
This is some text inside of a div block.
(C19048)
London Bridge

We are looking for up to 10 men and women with Wilson Disease aged 18 years or older to test a potential medicine for treating Wilson Disease.

Pemphigus Vulgaris (PV) patients aged between 18 to 70

£1,524
Age:
18-70
London Bridge
(C20028) Part B

We are conducting a clinical trial for a potential new medicine that could be used to treat people with Pemphigus Vulgaris (PV).

Pemphigus Vulgaris (PV) patients aged between 18 to 70

£1,524
This is some text inside of a div block.
(C20028) Part B
London Bridge

We are conducting a clinical trial for a potential new medicine that could be used to treat people with Pemphigus Vulgaris (PV).